Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-16269110 in Overweight and Obese Subjects
NCT00622765Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Nov 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of usistapide in obesity, Overweight, sponsored by Johnson & Johnson. Started Nov 2007; status: completed.
02
Drugs
usistapide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT00622765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622765.